A new study published today in Stem Cell Reports demonstrates how a human stem cell-derived model of the intestine can be used to identify potential therapies for inflammatory bowel disease (IBD), highlighting glycyrrhizin as a promising candidate for reducing intestinal inflammation and cell death.

‍The burden of IBD is rising globally, with an estimated 4 million people affected worldwide. The disease is characterized by chronic inflammation of the intestinal wall, leading to symptoms such as persistent diarrhea, abdominal pain, and fatigue. Standard treatments include anti-inflammatory drugs and other immune-targeting therapies, but many patients experience only limited benefit.

New episode revisits leading voices and major advances featured on the podcast

‍The International Society for Stem Cell Research (ISSCR) today announced the release of a special anniversary episode of The Stem Cell Report podcast, “Stem Cell-ebration: 5 Years of Breakthrough Science and Insightful Conversations,” marking five years of exploring the science, people, and stories shaping the field. The podcast features work that has published in the ISSCR’s journal, Stem Cell Reports.

The International Society for Stem Cell Research (ISSCR) announces that Stem Cell Reports, its official open-access, peer-reviewed journal, has been named the official journal of the BaCell 3D Organoid Conference, taking place 22-24 June 2026 in Basel, Switzerland.

‍BaCell 3D brings together leading scientists, innovators, and industry experts at the forefront of organoid technologies, microphysiological systems, and disease modeling. Held annually in one of Europe’s most vibrant life science hubs, the meeting fosters global collaboration and accelerates advances in in vitro multicellular systems that are transforming biomedical research.

The International Society for Stem Cell Research (ISSCR) is pleased to announce the appointment of Hongmei Wang, Ph.D., as an Associate Editor of its journal, Stem Cell Reports. Dr. Wang is a professor of State Key Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology (IOZ), Chinese Academy of Sciences (CAS).

‍An internationally recognized leader in developmental and reproductive biology, Dr. Wang brings deep expertise in early embryo and placental development, and advanced in vitro modeling systems. Her laboratory investigates the mechanisms that govern embryonic and placental development in non-human primates and humans, with the long-term goal of improving understanding of pregnancy health and exploring culture systems that support extra-uterine embryogenesis. Her work advances understanding of developmental diseases and holds potential for improving reproductive health outcomes.